Literature DB >> 22956757

Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity.

Aline Dias Paiva1, Michelle Dias de Oliveira, Sérgio Oliveira de Paula, Maria Cristina Baracat-Pereira, Eefjan Breukink, Hilário Cuquetto Mantovani.   

Abstract

Bacteriocins are ribosomally synthesized antimicrobial peptides produced by Bacteria and some Archaea. The assessment of the toxic potential of antimicrobial peptides is important in order to apply these peptides on an industrial scale. The aim of the present study was to investigate the in vitro cytotoxic and haemolytic potential of bovicin HC5, as well as to determine whether cholesterol influences bacteriocin activity on model membranes. Nisin, for which the mechanism of action is well described, was used as a reference peptide in our assays. The viability of three distinct eukaryotic cell lines treated with bovicin HC5 or nisin was analysed by using the MTT assay and cellular morphological changes were determined by light microscopy. The haemolytic potential was evaluated by using the haemoglobin liberation assay and the role of cholesterol on bacteriocin activity was examined by using model membranes composed of DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) and DPoPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine). The IC(50) of bovicin HC5 and nisin against Vero cells was 65.42 and 13.48 µM, respectively. When the MTT assay was performed with MCF-7 and HepG2 cells, the IC(50) obtained for bovicin HC5 was 279.39 and 289.30 µM, respectively, while for nisin these values were 105.46 and 112.25 µM. The haemolytic activity of bovicin HC5 against eukaryotic cells was always lower than that determined for nisin. The presence of cholesterol did not influence the activity of either bacteriocin on DOPC model membranes, but nisin showed reduced carboxyfluorescein leakage in DPoPC membranes containing cholesterol. In conclusion, bovicin HC5 only exerted cytotoxic effects at concentrations that were greater than the concentration needed for its biological activity, and the presence of cholesterol did not affect its interaction with model membranes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956757     DOI: 10.1099/mic.0.062190-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  34 in total

1.  Construction, heterologous expression, partial purification, and in vitro cytotoxicity of the recombinant plantaricin E produced by Lactococcus lactis against Enteropathogenic Escherichia coli K.1.1 and human cervical carcinoma (HeLa) cells.

Authors:  Apon Zaenal Mustopa; Siti Mariyah; Sri Budiarti; Hidayah Murtiyaningsih; Wida Nurul Alfisyahrin
Journal:  Mol Biol Rep       Date:  2018-07-31       Impact factor: 2.316

2.  Biomedical applications of L-alanine produced by Pediococcus acidilactici BD16 (alaD+).

Authors:  Anshula Sharma; Vikrant Mehta; Suman Rani; Masafumi Noda; Masanori Sugiyama; Harish Chander; Baljinder Kaur
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-28       Impact factor: 4.813

3.  In vitro assessment of skin sensitization, irritability and toxicity of bacteriocins and reuterin for possible topical applications.

Authors:  Samira Soltani; Yvan Boutin; Frédéric Couture; Eric Biron; Muriel Subirade; Ismail Fliss
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

Review 4.  Bovicins: The Bacteriocins of Streptococci and Their Potential in Methane Mitigation.

Authors:  Anita Kumari Garsa; Prasanta Kumar Choudhury; Anil Kumar Puniya; Tejpal Dhewa; Ravinder Kumar Malik; Sudhir Kumar Tomar
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

5.  Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells.

Authors:  Karim Naghmouchi; John Baah; Didier Hober; Eric Jouy; Cédric Rubrecht; Famara Sané; Djamel Drider
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

6.  The Antimicrobial Peptide, Nisin, Synergistically Enhances the Cytotoxic and Apoptotic Effects of Rituximab Treatment on Human Burkitt's Lymphoma Cell Lines.

Authors:  Pantea Mohammadi; Mina Zangeneh; Hamid-Reza Mohammadi-Motlagh; Fatemeh Khademi
Journal:  Rep Biochem Mol Biol       Date:  2020-10

7.  Safety evaluation of the antimicrobial peptide bovicin HC5 orally administered to a murine model.

Authors:  Aline Dias Paiva; Kenner Morais Fernandes; Roberto Sousa Dias; Alípio dos Santos Rocha; Leandro Licursi de Oliveira; Clóvis Andrade Neves; Sérgio Oliveira de Paula; Hilário Cuquetto Mantovani
Journal:  BMC Microbiol       Date:  2013-03-27       Impact factor: 3.605

8.  A peptide factor secreted by Staphylococcus pseudintermedius exhibits properties of both bacteriocins and virulence factors.

Authors:  Benedykt Wladyka; Marcin Piejko; Monika Bzowska; Piotr Pieta; Monika Krzysik; Łukasz Mazurek; Ibeth Guevara-Lora; Michał Bukowski; Artur J Sabat; Alexander W Friedrich; Emilia Bonar; Jacek Międzobrodzki; Adam Dubin; Paweł Mak
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

Review 9.  Bacteriocins as Potential Anticancer Agents.

Authors:  Sumanpreet Kaur; Sukhraj Kaur
Journal:  Front Pharmacol       Date:  2015-11-10       Impact factor: 5.810

10.  In vitro toxicity determination of antifungal constituents from Combretum zeyheri.

Authors:  Santana Mapfunde; Simbarashe Sithole; Stanley Mukanganyama
Journal:  BMC Complement Altern Med       Date:  2016-06-02       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.